Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Impel NeuroPharma enrolls last patient in phase 3 migraine trial of INP104
Image: Impel NeuroPharma announces last patient enrolled in phase 3 trial evaluating INP104 for the treatment of acute migraine. Photo: courtesy of mwooten/Pixabay.
Image: Impel NeuroPharma announces last patient enrolled in phase 3 trial evaluating INP104 for the treatment of acute migraine. Photo: courtesy of mwooten/Pixabay.